Cargando…
The utility of [(18)F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate-Resistant Prostate Cancer Patients (nmCRPCp): diagnostic performance and impact on management
OBJECTIVE: To evaluate the role of [(18)F]Fluciclovine PET/CT scan in restaging nmCRPCp and its impact on management. METHODS AND MATERIALS: This retrospective study included all patients with nonmetastatic castrate-resistant prostate cancer, who underwent [(18)F]Fluciclovine PET/CT scans for restag...
Autores principales: | Soliman, Moataz, Elfatairy, Kareem, Ellessy, Reham, Velichko, Yury S, Avery, Ryan, kelahan, Linda C, Ross, Ashley E, Savas, Hatice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646647/ https://www.ncbi.nlm.nih.gov/pubmed/37750841 http://dx.doi.org/10.1259/bjr.20230414 |
Ejemplares similares
-
Primary splenic lymphoma on top of intrahepatic splenosis: A unique case report
por: Soliman, Moataz, et al.
Publicado: (2022) -
Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review
por: Cattrini, Carlo, et al.
Publicado: (2022) -
Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014) -
Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer
por: Patel, Urvi J., et al.
Publicado: (2019) -
In Molecular Pursuit of Bone Metastasis by Fluciclovine PET
por: Lindenberg, Liza
Publicado: (2017)